|
1
|
Wang Y and Jiang T: Understanding high
grade glioma: molecular mechanism, therapy and comprehensive
management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakada M, Kita D, Teng L, et al: Receptor
tyrosine kinases: principles and functions in glioma invasion. Adv
Exp Med Biol. 986:143–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kwiatkowska A and Symons M: Signaling
determinants of glioma cell invasion. Adv Exp Med Biol.
986:121–141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagadia R, Pandit P, Coman WB,
Cooper-White J and Punyadeera C: miRNAs in head and neck cancer
revisited. Cell Oncol (Dordr). 36:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Q, Li P, Li A, et al: Plasma specific
miRNAs as predictive biomarkers for diagnosis and prognosis of
glioma. J Exp Clin Cancer Res. 31:972012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asadi-Moghaddam K, Chiocca EA and Lawler
SE: Potential role of miRNAs and their inhibitors in glioma
treatment. Expert Rev Anticancer Ther. 10:1753–1762. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rani SB, Rathod SS, Karthik S, Kaur N,
Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive
RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro
Oncol. 15:1302–1316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu Y, Chopp M, Zheng X, Katakowski M,
Buller B and Jiang F: MiR-145 reduces ADAM17 expression and
inhibits in vitro migration and invasion of glioma cells.
Oncol Rep. 29:67–72. 2013.PubMed/NCBI
|
|
10
|
Lee SJ, Kim SJ, Seo HH, et al:
Over-expression of miR-145 enhances the effectiveness of HSVtk gene
therapy for malignant glioma. Cancer Lett. 320:72–80. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Speranza MC, Frattini V, Pisati F, et al:
NEDD9, a novel target of miR-145, increases the invasiveness of
glioblastoma. Oncotarget. 3:723–734. 2012.PubMed/NCBI
|
|
12
|
Chen RH, Wang WJ and Kuo JC: The tumor
suppressor DAP-kinase links cell adhesion and cytoskeleton
reorganization to cell death regulation. J Biomed Sci. 13:193–199.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Becart S and Altman A: SWAP-70-like
adapter of T cells: a novel Lck-regulated guanine nucleotide
exchange factor coordinating actin cytoskeleton reorganization and
Ca2+ signaling in T cells. Immunol Rev. 232:319–333.
2009. View Article : Google Scholar
|
|
14
|
Hall A: Rho family GTPases. Biochem Soc
Trans. 40:1378–1382. 2012. View Article : Google Scholar
|
|
15
|
Schofield AV and Bernard O: Rho-associated
coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem
Mol Biol. 48:301–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bu Q, Tang HM, Tan J, Hu X and Wang DW:
Expression of RhoC and ROCK-1 and their effects on MAPK and Akt
proteins in prostate carcinoma. Zhonghua Zhong Liu Za Zhi.
33:202–206. 2011.(In Chinese).
|
|
18
|
Majid S, Dar AA, Saini S, et al:
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1
in bladder cancer. PLoS One. 7:e467432012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oellers P, Schroer U, Senner V, Paulus W
and Thanos S: ROCKs are expressed in brain tumors and are required
for glioma-cell migration on myelinated axons. Glia. 57:499–509.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inaba N, Ishizawa S, Kimura M, et al:
Effect of inhibition of the ROCK isoform on RT2 malignant glioma
cells. Anticancer Res. 30:3509–3514. 2010.PubMed/NCBI
|
|
22
|
Hadler-Olsen E, Winberg JO and
Uhlin-Hansen L: Matrix metalloproteinases in cancer: their value as
diagnostic and prognostic markers and therapeutic targets. Tumour
Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Villadsen SB, Bramsen JB, Ostenfeld MS, et
al: The miR-143/-145 cluster regulates plasminogen activator
inhibitor-1 in bladder cancer. Br J Cancer. 106:366–374. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiyomaru T, Tatarano S, Kawakami K, et
al: SWAP70, actin-binding protein, function as an oncogene
targeting tumor-suppressive miR-145 in prostate cancer. Prostate.
71:1559–1567. 2011.PubMed/NCBI
|
|
25
|
Zhang J, Guo H, Zhang H, et al: Putative
tumor suppressor miR-145 inhibits colon cancer cell growth by
targeting oncogene Friend leukemia virus integration 1 gene.
Cancer. 117:86–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee HK, Bier A, Cazacu S, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morgan-Fisher M, Wewer UM and Yoneda A:
Regulation of ROCK activity in cancer. J Histochem Cytochem.
61:185–198. 2013. View Article : Google Scholar
|
|
28
|
Wen S, Shang Z, Zhu S, Chang C and Niu Y:
Androgen receptor enhances entosis, a non-apoptotic cell death,
through modulation of Rho/ROCK pathway in prostate cancer cells.
Prostate. 73:1306–1315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Sun L, Yang M, et al: DEK
depletion negatively regulates Rho/ROCK/MLC pathway in non-small
cell lung cancer. J Histochem Cytochem. 61:510–521. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang AT, Campbell WB and Nithipatikom K:
ROCK1 feedback regulation of the upstream small GTPase RhoA. Cell
Signal. 24:1375–1380. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Imamura F, Mukai M, Ayaki M and Akedo H:
Y-27632, an inhibitor of rho-associated protein kinase, suppresses
tumor cell invasion via regulation of focal adhesion and focal
adhesion kinase. Jpn J Cancer Res. 91:811–816. 2000. View Article : Google Scholar : PubMed/NCBI
|
